0% found this document useful (0 votes)
46 views5 pages

An Iron Age For Cancer Therapy Nature Nanotechnology

Two reports show that FDA-approved nanoparticles can selectively kill cancer cells by increasing iron levels and reactive oxygen species accumulation. The nanoparticles kill cancer cells through iron- and reactive oxygen species-dependent mechanisms, offering new strategies for cancer treatment that exploit cancer cells' higher sensitivity to oxidative stress compared to normal cells.

Uploaded by

Miguel Angel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
46 views5 pages

An Iron Age For Cancer Therapy Nature Nanotechnology

Two reports show that FDA-approved nanoparticles can selectively kill cancer cells by increasing iron levels and reactive oxygen species accumulation. The nanoparticles kill cancer cells through iron- and reactive oxygen species-dependent mechanisms, offering new strategies for cancer treatment that exploit cancer cells' higher sensitivity to oxidative stress compared to normal cells.

Uploaded by

Miguel Angel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 5

View all journals Search Login

Content About Publish Sign up for alerts RSS feed

Published: 26 September 2016

Nanomedicine
An iron age for cancer therapy
Amy Tarangelo & Scott J. Dixon  

Nature Nanotechnology  11, 921–922 (2016)


5777 Accesses 50 Citations 5 Altmetric Metrics

Two reports show FDA-approved nanoparticles can kill cancer cells through iron- and
reactive oxygen species-dependent mechanisms, offering new strategies for cancer
treatment.

Iron is found in all mammalian cells and is required for cell growth and division. However, iron
levels must be tightly controlled, as iron can catalyse the formation of toxic reactive oxygen
species (ROS). Rapidly proliferating cancer cells often contain more iron than normal cells and,
perhaps for this reason, are more sensitive to ROS stress1,2. Whether it is possible to exploit this
sensitivity to treat cancer by increasing iron levels, ROS accumulation or both processes, is
unclear. Now, two reports in Nature Nanotechnology identify two Food and Drug
Administration (FDA)-approved nanoparticles that can selectively kill cancer cells by
This is a preview of subscription content, access via your institution

Relevant articles
Open Access articles citing this article.

Intracellular marriage of bicarbonate and Mn ions as “immune ion reactors” to


regulate redox homeostasis and enhanced antitumor immune responses

Yushuo Feng, Yaqing Liu … Hongmin Chen


Journal of Nanobiotechnology Open Access 19 April 2022

Carbonized paramagnetic complexes of Mn (II) as contrast agents for precise


magnetic resonance imaging of sub-millimeter-sized orthotopic tumors

Ruixue Qin, Shi Li … Hongmin Chen


Nature Communications Open Access 11 April 2022

Transformable hybrid semiconducting polymer nanozyme for second near-


infrared photothermal ferrotherapy

Yuyan Jiang, Xuhui Zhao … Ruiping Zhang


Nature Communications Open Access 20 April 2020

Access options

Buy article Subscribe to


Get time limited or full article Journal
access on ReadCube.
Get full journal access for 1
year

$32.00
We are sorry, but there is no personal subscription option
available for your country.

Buy
More Information
All prices are NET prices.

Additional access options:

• Log in
• Learn about institutional subscriptions

References

1 Torti, S. V. & Torti, F. M. Nat. Rev. Cancer 13, 342–355 (2013).

2 Trachootham, D., Alexandre, J. & Huang, P. Nat. Rev. Drug Discov. 8, 579–591 (2009).

3 Kim, S. E. et al. Nat. Nanotech. 11, 977–985(2016).


4 Zanganeh, S. et al. Nat. Nanotech. 11, 986–994 (2016).

5 Dixon, S. J. et al. Cell 149, 1060–1072 (2012).

6 Gao, M. et al. Mol. Cell 59, 298–308 (2015).

7 Qian, B. Z. & Pollard, J. W. Cell 141, 39–51 (2010).

8 Sarosiek, K. A. et al. Mol. Cell 51, 751–765 (2013).

Author information

Authors and Affiliations


Amy Tarangelo and Scott J. Dixon are in the Program in Cancer Biology and the Department of Biology, Stanford University, Room 104, 337 Campus
Drive, Stanford, California 94305, USA,
Amy Tarangelo & Scott J. Dixon

Corresponding author
Correspondence to Scott J. Dixon.

Rights and permissions

Reprints and Permissions

About this article

Cite this article


Tarangelo, A., Dixon, S. An iron age for cancer therapy. Nature Nanotech 11, 921–922 (2016).
https://doi.org/10.1038/nnano.2016.199

Published Issue Date


26 September 2016 November 2016

DOI
https://doi.org/10.1038/nnano.2016.199
Subjects Nanotechnology in cancer

This article is cited by

Intracellular marriage of bicarbonate and Mn ions as “immune ion reactors” to


regulate redox homeostasis and enhanced antitumor immune responses
Yushuo Feng , Yaqing Liu ... Hongmin Chen

Journal of Nanobiotechnology (2022)

Carbonized paramagnetic complexes of Mn (II) as contrast agents for precise


magnetic resonance imaging of sub-millimeter-sized orthotopic tumors
Ruixue Qin , Shi Li ... Hongmin Chen

Nature Communications (2022)

The ancillary effects of nanoparticles and their implications for nanomedicine


Evan P. Stater , Ali Y. Sonay ... Jan Grimm

Nature Nanotechnology (2021)

Transformable hybrid semiconducting polymer nanozyme for second near-


infrared photothermal ferrotherapy
Yuyan Jiang , Xuhui Zhao ... Ruiping Zhang

Nature Communications (2020)

Magnetic nanoparticles based cancer therapy: current status and applications


Huan Zhang , Xiao Li Liu ... Hai Ming Fan

Science China Life Sciences (2018)

Nature Nanotechnology (Nat. Nanotechnol.) ISSN 1748-3395 (online) ISSN 1748-3387 (print)

© 2022 Springer Nature Limited

You might also like